Pharmacogenetics of Drug-Resistant Epilepsy (Review of Literature)

Pharmacogenomic studies in epilepsy are justified by the high prevalence rate of this disease and the high cost of its treatment, frequent drug resistance, different response to the drug, the possibility of using reliable methods to assess the control of seizures and side effects of antiepileptic dr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Beata Smolarz, Marianna Makowska, Hanna Romanowicz
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/c68f30162e31451aa5392754ce9032a4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c68f30162e31451aa5392754ce9032a4
record_format dspace
spelling oai:doaj.org-article:c68f30162e31451aa5392754ce9032a42021-11-11T17:09:22ZPharmacogenetics of Drug-Resistant Epilepsy (Review of Literature)10.3390/ijms2221116961422-00671661-6596https://doaj.org/article/c68f30162e31451aa5392754ce9032a42021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11696https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Pharmacogenomic studies in epilepsy are justified by the high prevalence rate of this disease and the high cost of its treatment, frequent drug resistance, different response to the drug, the possibility of using reliable methods to assess the control of seizures and side effects of antiepileptic drugs. Candidate genes encode proteins involved in pharmacokinetic processes (drug transporters, metabolizing enzymes), pharmacodynamic processes (receptors, ion channels, enzymes, regulatory proteins, secondary messengers) and drug hypersensitivity (immune factors). This article provides an overview of the literature on the influence of genetic factors on treatment in epilepsy.Beata SmolarzMarianna MakowskaHanna RomanowiczMDPI AGarticlepharmacogeneticsdrug-resistant epilepsygenesCYP2 familyMDR-1GABA receptorsBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11696, p 11696 (2021)
institution DOAJ
collection DOAJ
language EN
topic pharmacogenetics
drug-resistant epilepsy
genes
CYP2 family
MDR-1
GABA receptors
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle pharmacogenetics
drug-resistant epilepsy
genes
CYP2 family
MDR-1
GABA receptors
Biology (General)
QH301-705.5
Chemistry
QD1-999
Beata Smolarz
Marianna Makowska
Hanna Romanowicz
Pharmacogenetics of Drug-Resistant Epilepsy (Review of Literature)
description Pharmacogenomic studies in epilepsy are justified by the high prevalence rate of this disease and the high cost of its treatment, frequent drug resistance, different response to the drug, the possibility of using reliable methods to assess the control of seizures and side effects of antiepileptic drugs. Candidate genes encode proteins involved in pharmacokinetic processes (drug transporters, metabolizing enzymes), pharmacodynamic processes (receptors, ion channels, enzymes, regulatory proteins, secondary messengers) and drug hypersensitivity (immune factors). This article provides an overview of the literature on the influence of genetic factors on treatment in epilepsy.
format article
author Beata Smolarz
Marianna Makowska
Hanna Romanowicz
author_facet Beata Smolarz
Marianna Makowska
Hanna Romanowicz
author_sort Beata Smolarz
title Pharmacogenetics of Drug-Resistant Epilepsy (Review of Literature)
title_short Pharmacogenetics of Drug-Resistant Epilepsy (Review of Literature)
title_full Pharmacogenetics of Drug-Resistant Epilepsy (Review of Literature)
title_fullStr Pharmacogenetics of Drug-Resistant Epilepsy (Review of Literature)
title_full_unstemmed Pharmacogenetics of Drug-Resistant Epilepsy (Review of Literature)
title_sort pharmacogenetics of drug-resistant epilepsy (review of literature)
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/c68f30162e31451aa5392754ce9032a4
work_keys_str_mv AT beatasmolarz pharmacogeneticsofdrugresistantepilepsyreviewofliterature
AT mariannamakowska pharmacogeneticsofdrugresistantepilepsyreviewofliterature
AT hannaromanowicz pharmacogeneticsofdrugresistantepilepsyreviewofliterature
_version_ 1718432202562207744